Non-functioning pituitary adenoma: When and how to operate? What pathologic criteria for typing?
Frédéric Castinetti(Inserm), Jacqueline Trouillas, Alexandre Vasiljevic(Centre de Recherche en Neurosciences de Lyon), Chiara Villa(Centre National de la Recherche Scientifique), Henry Dufour(Inserm), Emmanuel Jouanneau(Hôpital Pierre Wertheimer)
Cited by 36
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357